551 related articles for article (PubMed ID: 31858615)
21. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
22. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
23. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
24. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
25. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
26. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
Hanna GB; Boshier PR; Markar SR; Romano A
JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
[TBL] [Abstract][Full Text] [Related]
27. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
28. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
29. The use of the PEN3 e-nose in the screening of colorectal cancer and polyps.
Altomare DF; Porcelli F; Picciariello A; Pinto M; Di Lena M; Caputi Iambrenghi O; Ugenti I; Guglielmi A; Vincenti L; De Gennaro G
Tech Coloproctol; 2016 Jun; 20(6):405-409. PubMed ID: 27000856
[No Abstract] [Full Text] [Related]
30. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
[TBL] [Abstract][Full Text] [Related]
32. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
33. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a 92 multiplex protein panel in detection of colorectal cancer and high-risk adenoma in 784 symptomatic individuals.
Rasmussen L; Nielsen HJ; Christensen IJ
Cancer Biomark; 2021; 32(1):73-84. PubMed ID: 34092616
[TBL] [Abstract][Full Text] [Related]
35. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
36. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
37. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
[TBL] [Abstract][Full Text] [Related]
38. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
39. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
[TBL] [Abstract][Full Text] [Related]
40. The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening.
Abdullah M; Rani AA; Simadibrata M; Fauzi A; Syam AF
Acta Med Indones; 2012 Apr; 44(2):94-9. PubMed ID: 22745138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
